{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:08:55Z","timestamp":1758845335345,"version":"3.32.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1983,12,1]],"date-time":"1983-12-01T00:00:00Z","timestamp":439084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Tr"],"published-print":{"date-parts":[[1983,12]]},"DOI":"10.1007\/bf01807588","type":"journal-article","created":{"date-parts":[[2005,6,28]],"date-time":"2005-06-28T03:27:30Z","timestamp":1119929250000},"page":"355-364","source":"Crossref","is-referenced-by-count":25,"title":["Relation of estrogen and\/or progesterone receptor content of breast cancer to patient outcome following adjuvant chemotherapy"],"prefix":"10.1007","volume":"3","author":[{"given":"Bernard","family":"Fisher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol K.","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Lawrence","family":"Wickerham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard E.","family":"Rockette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Allegra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Plotkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"other NSABP investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01807588_CR1","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1002\/1097-0142(197706)39:6<2934::AID-CNCR2820390680>3.0.CO;2-P","volume":"39","author":"WL McGuire","year":"1977","unstructured":"McGuire WL, Horwitz KB, Pearson OH, Segaloff A: Current status of estrogen and progesterone receptors in breast cancer. Cancer 39:2934\u20132947, 1977","journal-title":"Cancer"},{"key":"BF01807588_CR2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJM197806012982203","volume":"298","author":"ME Lippman","year":"1978","unstructured":"Lippman ME, Allegra JC, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HMT, Aitken SC, Warren R: The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. N Engl J Med 298:1223\u20131228, 1978","journal-title":"N Engl J Med"},{"key":"BF01807588_CR3","first-page":"4305","volume":"38","author":"W Jonat","year":"1978","unstructured":"Jonat W, Maass H: Some comments on the necessity of receptor determination in human breast cancer. Cancer Res 38:4305\u20134306, 1978","journal-title":"Cancer Res"},{"key":"BF01807588_CR4","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM197905033001813","volume":"300","author":"M Kaufmann","year":"1979","unstructured":"Kaufmann M, Klinga K, Runnebaum B, Kubli F: Hormone receptors in breast cancer and response to chemotherapy. (Letter to Editor). N Engl J Med 300:1052, 1979","journal-title":"N Engl J Med"},{"key":"BF01807588_CR5","unstructured":"Frenning DH, Kennedy BJ, Vosika GJ, Kiang DT: Correlation of estrogen receptors and response to chemotherapy in advanced breast cancer. ASCO Abstracts, March 1978, p 347"},{"key":"BF01807588_CR6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM197812142992403","volume":"299","author":"DT Kiang","year":"1978","unstructured":"Kiang DT, Frenning DH, Goldman AI, Ascensao VF, Kennedy BJ: Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med 299:1330\u20131334, 1978","journal-title":"N Engl J Med"},{"key":"BF01807588_CR7","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/1097-0142(19801215)46:12+<2814::AID-CNCR2820461415>3.0.CO;2-D","volume":"46","author":"DT Kiang","year":"1980","unstructured":"Kiang DT, Frenning DH, Gay J, Goldman AI, Kennedy BJ: Estrogen receptor status and response to chemotherapy in advanced breast cancer. Cancer 46:2814\u20132817, 1980","journal-title":"Cancer"},{"key":"BF01807588_CR8","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(19801215)46:12+<2961::AID-CNCR2820461444>3.0.CO;2-E","volume":"46","author":"PCM Young","year":"1980","unstructured":"Young PCM, Ehrlich CE, Einhorn LH: Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer. Cancer 46:2961\u20132963, 1980","journal-title":"Cancer"},{"key":"BF01807588_CR9","first-page":"763","volume":"65","author":"J Mortimer","year":"1981","unstructured":"Mortimer J, Reimer R, Greenstreet R, Groppe C, Bukowski R: Influence of estrogen receptor status on response to combination chemotherapy for recurrent breast cancer. Cancer Treat Rep 65:763\u2013766, 1981","journal-title":"Cancer Treat Rep"},{"key":"BF01807588_CR10","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/1097-0142(19811201)48:11<2503::AID-CNCR2820481126>3.0.CO;2-T","volume":"48","author":"JC Chang","year":"1981","unstructured":"Chang JC, Wergowske G: Correlation of estrogen receptors and response to chemotherapy of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in advanced breast cancer. Cancer 48:2503\u20132506, 1981","journal-title":"Cancer"},{"key":"BF01807588_CR11","first-page":"70","volume":"152","author":"JF Paone","year":"1981","unstructured":"Paone JF, Abeloff MD, Ettinger DS, Arnold EA, Baker RR: The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast. Surg Gynecol Obstet 152:70\u201374, 1981","journal-title":"Surg Gynecol Obstet"},{"key":"BF01807588_CR12","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/1097-0142(19801215)46:12+<2797::AID-CNCR2820461411>3.0.CO;2-B","volume":"46","author":"R Hilf","year":"1980","unstructured":"Hilf R, Feldstein ML, Savlov ED, Gibson SL, Seneca B: The lack of relationship between estrogen receptor status and response to chemotherapy. Cancer 46:2797\u20132800, 1980","journal-title":"Cancer"},{"key":"BF01807588_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00255457","volume":"4","author":"RD Rubens","year":"1980","unstructured":"Rubens RD, King RJB, Sexton S, Minton MJ, Hayward JL: Oestrogen receptors and response to cytotoxic chemotherapy in advanced breast cancer. Cancer Chemother Pharmacol 4:43\u201345, 1980","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF01807588_CR14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/1097-0142(19800415)45:8<1993::AID-CNCR2820450802>3.0.CO;2-2","volume":"45","author":"R Hilf","year":"1980","unstructured":"Hilf R, Feldstein ML, Gibson SL, Savlov ED: The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer. Cancer 45:1993\u20132000, 1980","journal-title":"Cancer"},{"key":"BF01807588_CR15","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/1097-0142(19801215)46:12+<2919::AID-CNCR2820461434>3.0.CO;2-X","volume":"46","author":"C Rosenbaum","year":"1980","unstructured":"Rosenbaum C, Marsland TA, Stolbach LL, Raam S, Cohen JL: Estrogen receptor status and response to chemotherapy in advanced breast cancer: The Tufts-Shattuck-Pondville Experience. Cancer 46:2919\u20132921, 1980","journal-title":"Cancer"},{"key":"BF01807588_CR16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00255456","volume":"4","author":"G Bonadonna","year":"1980","unstructured":"Bonadonna G, Valagussa P, Tancini G, Di Fronzo G: Estrogen receptors status and response to chemotherapy in early and advanced breast cancer. Cancer Chemother Pharmacol 4:37\u201341, 1980","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF01807588_CR17","first-page":"386","volume":"88","author":"PV Gapinski","year":"1980","unstructured":"Gapinski PV, Donegan WL: Estrogen receptors and breast cancer: Prognostic and therapeutic implications. Surgery 88:386\u2013393, 1980","journal-title":"Surgery"},{"key":"BF01807588_CR18","unstructured":"Rosner D, Nemoto T: A randomized study of two and three drug regimen in relation with estrogen receptors in metastatic breast cancer. ASCO Abstracts, 1979, p 46"},{"key":"BF01807588_CR19","first-page":"49","volume":"2","author":"SK Carter","year":"1979","unstructured":"Carter SK: The dilemma of estrogen receptors and the response rate to cytotoxic chemotherapy: A problem of comparability analysis. Cancer Clin Trials 2:49\u201353, 1979","journal-title":"Cancer Clin Trials"},{"key":"BF01807588_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-3-642-81685-7_25","volume":"80","author":"G Bonadonna","year":"1982","unstructured":"Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambilla C, Marchini S, Veronesi U: Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: The Milan Institute experience. Rec Results Cancer Res 80:149\u2013156, 1982","journal-title":"Rec Results Cancer Res"},{"key":"BF01807588_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198107023050101","volume":"305","author":"B Fisher","year":"1981","unstructured":"Fisher B, Redmond C, Brown A, Wolmark N, Wittliff J, Fisher ER, Plotkin D, Bowman D, Sachs S, Wolter J, Frelick R, Desser R, LiCalzi N, Geggie P, Campbell T, Elias EG, Prager D, Koontz P, Volk H, Dimitrov N, Gardner B, Lerner H, Shibata H, and Other NSABP Investigators: Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med 305:1\u20136, 1981","journal-title":"N Engl J Med"},{"key":"BF01807588_CR22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1200\/JCO.1983.1.4.227","volume":"1","author":"B Fisher","year":"1983","unstructured":"Fisher B, Redmond C, Brown A, Wickerham DL, Wolmark N, Allegra J, Escher G, Lippman M, Savlov E, Wittliff J, and Fisher ER, with the contributions of Plotkin D, Bowman D, Wolter J, Bornstein R, Desser R, Frelick R, and Other NSABP Investigators: Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer. J. Clin Oncol 1:227\u2013241, 1983","journal-title":"J. Clin Oncol"},{"key":"BF01807588_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJM197501162920301","volume":"292","author":"B Fisher","year":"1975","unstructured":"Fisher B, Carbone P, Economou SG, Frelick R, Glass A, Lerner H, Redmond C, Zelen M, Band P, Katrych DL, Wolmark N, Fisher ER, and Other Cooperative Investigators: 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer: A report of early findings. N Engl J Med 292:117\u2013122, 1975","journal-title":"N Engl J Med"},{"key":"BF01807588_CR24","first-page":"477","volume":"67","author":"DP Byar","year":"1980","unstructured":"Byar DP, Green SB: The choice of treatment for cancer patients based on covariate information: Application to prostate cancer. Bull Cancer 67:477\u2013490, 1980","journal-title":"Bull Cancer"},{"key":"BF01807588_CR25","volume-title":"Survival Models and Data Analysis","author":"RC Elandt-Johnson","year":"1980","unstructured":"Elandt-Johnson RC, Johnson NL: Survival Models and Data Analysis, John Wiley & Sons, New York, 1980"},{"key":"BF01807588_CR26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR: Regression models and life-tables. J Roy Stat Soc (B) 34:187\u2013220, 1972","journal-title":"J Roy Stat Soc (B)"},{"key":"BF01807588_CR27","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163\u2013170, 1966","journal-title":"Cancer Chemother Rep"},{"key":"BF01807588_CR28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2307\/2344317","volume":"135","author":"R Peto","year":"1972","unstructured":"Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J Roy Stat Soc (A) 135:185\u2013206, 1972","journal-title":"J Roy Stat Soc (A)"},{"key":"BF01807588_CR29","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(79)92752-1","volume":"1","author":"T Cooke","year":"1979","unstructured":"Cooke T, George D, Shields R, Maynard P, Griffiths K: Oestrogen receptors and prognosis in early breast cancer. Lancet 1:995\u2013997, 1979","journal-title":"Lancet"},{"key":"BF01807588_CR30","first-page":"4669","volume":"37","author":"WA Knight","year":"1977","unstructured":"Knight WA, Livingston RB, Gregory EJ, McGuire WL: Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37:4669\u20134671, 1977","journal-title":"Cancer Res"},{"key":"BF01807588_CR31","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/1097-0142(19810901)48:5<1215::AID-CNCR2820480527>3.0.CO;2-3","volume":"48","author":"AM Sarrif","year":"1981","unstructured":"Sarrif AM, Durant JR: Evidence that estrogen-receptor-negative, progesterone-receptor-positive breast and ovarian carcinomas contain estrogen receptor. Cancer 48:1215\u20131220, 1981","journal-title":"Cancer"},{"key":"BF01807588_CR32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1200\/JCO.1983.1.6.349","volume":"1","author":"B Fisher","year":"1983","unstructured":"Fisher B, Wickerham DL, Brown A, and Redmond CK, with the contributions of Cunningham TJ, Evans J, Legault-Poisson S, Paterson AHG, Schipper H, and Other NSABP Investigators: Breast cancer estrogen and progesterone receptor values: Their distribution, degree of concordance and relation to number of positive axillary nodes. J Clin Oncol 1:349\u2013358, 1983","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01807588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01807588\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01807588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T01:28:15Z","timestamp":1735781295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01807588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,12]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1983,12]]}},"alternative-id":["BF01807588"],"URL":"https:\/\/doi.org\/10.1007\/bf01807588","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[1983,12]]}}}